RedHill Biopharma Ltd. (RDHL)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$1.04
+0.97%
Mkt Cap $3.08M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q3 2025 Sep 5, 2025 | — | $2.04M | — | — | -$1.15 | — | — | — |
| Q4 2024 Oct 3, 2024 | — | — | — | — | $900.00 | — | — | — |
| Q3 2024 Aug 29, 2024 | $25.72M | — | — | -$30.00 | -$200.00 | -566.67% | — | — |
| Q1 2024 Feb 12, 2024 | $17.55M | — | — | -$0.03 | -$0.20 | -566.67% | — | — |
| Q2 2023 Jun 30, 2023 | $2.11M | $1.80M | -15.00% | — | $4.83 | — | — | — |
| Q2 2023 Jun 12, 2023 | $3.62M | $3.60M | -0.58% | — | $146.75 | — | — | — |
| Q1 2023 Mar 27, 2023 | $17.55M | $12.80M | -27.09% | — | $1.07 | — | — | — |
| Q4 2022 Nov 7, 2022 | $21.50M | $17.55M | -18.37% | -$0.30 | -$2.00 | -566.67% | — | — |
| Q3 2022 Sep 23, 2022 | $21.50M | $18.35M | -14.67% | — | -$10.04 | — | — | — |
| Q2 2022 Jun 23, 2022 | $23.60M | $18.24M | -22.73% | -$4.00 | -$3.00 | +25.00% | — | — |
| Q1 2022 Mar 17, 2022 | $24.09M | $22.07M | -8.37% | -$4.00 | -$5.00 | -25.00% | — | — |
| Q4 2021 Nov 30, 2021 | $24.52M | $21.61M | -11.87% | -$4.80 | -$4.60 | +4.17% | — | — |
| Q3 2021 Aug 26, 2021 | $27.00M | $21.50M | -20.36% | -$4.00 | -$6.20 | -55.00% | — | — |
| Q2 2021 May 27, 2021 | $34.31M | $20.57M | -40.04% | -$4.60 | -$5.30 | -15.22% | — | — |
| Q1 2021 Mar 18, 2021 | — | $21.46M | — | -$4.50 | -$7.00 | -55.56% | — | — |
| Q4 2020 Nov 12, 2020 | — | $20.94M | — | -$2.20 | -$5.00 | -127.27% | — | — |
| Q3 2020 Aug 13, 2020 | $3.67M | $20.90M | +470.23% | -$1.40 | -$4.50 | -221.43% | — | — |
| Q2 2020 May 27, 2020 | $735.08K | $1.06M | +43.66% | -$3.80 | -$4.90 | -28.95% | — | — |
| Q1 2020 Mar 4, 2020 | $724.11K | $1.59M | +119.58% | -$3.20 | -$3.00 | +6.25% | — | — |
| Q4 2019 Nov 19, 2019 | $1.60M | $1.40M | -12.50% | -$3.90 | -$3.00 | +23.08% | — | — |